110 related articles for article (PubMed ID: 29751991)
1. Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients.
Baert T; Van Camp J; Vanbrabant L; Busschaert P; Laenen A; Han S; Van Nieuwenhuysen E; Vergote I; Coosemans A
Gynecol Oncol; 2018 Jul; 150(1):31-37. PubMed ID: 29751991
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis.
Chen L; Wang X; Shu J; Xu S; Wu Q; Yu Y
Int J Gynaecol Obstet; 2019 Nov; 147(2):212-218. PubMed ID: 31469423
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses.
Yoshida A; Sarian LO; Marangoni M; Firmano IC; Derchain SF
Rev Bras Ginecol Obstet; 2020 Jul; 42(7):397-403. PubMed ID: 32559800
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.
Williams KA; Labidi-Galy SI; Terry KL; Vitonis AF; Welch WR; Goodman A; Cramer DW
Gynecol Oncol; 2014 Mar; 132(3):542-50. PubMed ID: 24462730
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer Patients with Low CA125 Concentration.
Zhang H; Huo Q; Huang L; Cheng Y; Liu Y; Bao H
Biomed Res Int; 2019; 2019():8107906. PubMed ID: 31341906
[TBL] [Abstract][Full Text] [Related]
6. CA125 modified by PLT and NLR improves the predictive accuracy of adenomyosis-derived pelvic dense adhesion.
Jiang C; Liu C; Guo J; Chen L; Luo N; Qu X; Yang W; Ren Q; Cheng Z
Medicine (Baltimore); 2017 May; 96(19):e6880. PubMed ID: 28489790
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
8. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
[TBL] [Abstract][Full Text] [Related]
9. The Use of Platelet/Lymphocyte Ratio and Cancer Antigen 125 Combined with Magnetic Resonance Diffusion-Weighted Imaging in Diagnosis of Recurrent Ovarian Cancer and Neuropathic Pain.
Wang N; Li C; Yang Y; Guan Y; Wang F; Wang Y; Zhao W
World Neurosurg; 2021 May; 149():502-510. PubMed ID: 33326856
[TBL] [Abstract][Full Text] [Related]
10. Does preoperative neutrophil to lymphocyte or platelet to lymphocyte ratios have a role in predicting borderline ovarian tumors?
Khatib G; Soysal C; Çetin C; Güleç ÜK; Güzel AB; Keskin N; Vardar MA; Gümürdülü D
J Ovarian Res; 2016 Nov; 9(1):78. PubMed ID: 27821183
[TBL] [Abstract][Full Text] [Related]
11. The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.
Seckin KD; Karslı MF; Yucel B; Bestel M; Yıldırım D; Canaz E; Akbayır O
Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():60-3. PubMed ID: 26683535
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the preoperative platelet count in the diagnosis of adnexal tumors.
Watrowski R; Heinze G; Jäger C; Forster J; Zeillinger R
Tumour Biol; 2016 Sep; 37(9):12079-12087. PubMed ID: 27207344
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between platelet count and CA-125 in ovarian cancer].
Friebe Z; Watrowski R; Bembnista M; Rokowska A; Włosiińska J; Dembińska M
Ginekol Pol; 2005 Mar; 76(3):187-94. PubMed ID: 16018136
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
[TBL] [Abstract][Full Text] [Related]
15. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
16. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion.
Polat M; Senol T; Ozkaya E; Ogurlu Pakay G; Cikman MS; Konukcu B; Ozten MA; Karateke A
Clin Transl Oncol; 2016 May; 18(5):457-63. PubMed ID: 26289552
[TBL] [Abstract][Full Text] [Related]
18. Use of Neutrophil-to-Lymphocyte Ratio Combined With CA-125 to Distinguish Endometriomas From Other Benign Ovarian Cysts.
Tokmak A; Yildirim G; Öztaş E; Akar S; Erkenekli K; Gülşen P; Yilmaz N; Uğur M
Reprod Sci; 2016 Jun; 23(6):795-802. PubMed ID: 26692541
[TBL] [Abstract][Full Text] [Related]
19. MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer.
Wu Y; Liu Q; Xie Y; Zhu J; Zhang S; Ge Y; Guo J; Luo N; Huang W; Xu R; Liu S; Cheng Z
J Ovarian Res; 2023 Aug; 16(1):181. PubMed ID: 37644468
[TBL] [Abstract][Full Text] [Related]
20. Serum CA125 level before the development of ovarian cancer.
Kobayashi H; Ooi H; Yamada Y; Sakata M; Kawaguchi R; Kanayama S; Sumimoto K; Terao T
Int J Gynaecol Obstet; 2007 Nov; 99(2):95-9. PubMed ID: 17643440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]